Viral hepatitis in minorities

被引:0
作者
Greta Szabo
Guy W. Neff
机构
[1] University of Cincinnati,Center for Digestive Diseases
关键词
Chronic Hepatitis; Lamivudine; Sustained Virologic Response; Adefovir; Adefovir Dipivoxil;
D O I
10.1007/s11901-005-0035-z
中图分类号
学科分类号
摘要
Treatment protocols for chronic liver disease caused by hepatitis C virus (HCV) and hepatitis B virus have different outcomes among various ethnic groups. Outcome information has been slowed by the limited number of trials aimed at the various ethnic minorities. The current opinion is that there is a vast difference in treatment success with antiviral therapies, especially with African-American men suffering from chronic HCV. This article investigates the up-to-date information in treatment outcomes for the two diseases, and liver transplant survivals.
引用
收藏
页码:92 / 96
页数:4
相关论文
共 145 条
  • [1] Younossi ZM(1997)Chronic hepatitis C: a clinical overview Cleve Clin J Med 64 259-268
  • [2] Hibbs JR(1992)Aplastic anemia and viral hepatitis. Non-A, Non-B, Non-C? JAMA 267 2051-2054
  • [3] Frickhofen N(1998)Predictors of patient and graft survival following liver transplantation for hepatitis C Hepatology 28 823-830
  • [4] Rosenfeld SJ(2002)Hepatitis C virus: the burden of the disease Acta Gastroenterol Belg 65 83-86
  • [5] Charlton M(2004)Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade Liver Transpl 0 1372-1378
  • [6] Seaberg E(1999)Natural history of chronic hepatitis B and C J Gastroenterol Hepatol 14 S1-S5
  • [7] Wiesner R(2005)Viral hepatitis in minority America J Clin Gastroenterol 39 144-151
  • [8] Adler M(2004)Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1 Hepatology 39 1702-1708
  • [9] Goubau P(2002)The burden of hepatitis C in the United States Hepatology 36 S30-S34
  • [10] Nevens F(1999)The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 341 556-562